Bisphosphonate-associated osteonecrosis can hide jaw metastases

Bone

Volumn 41, Issue 6, 2007, Pages 942-945

  Bedogni, Alberto ^a   Saia, Giorgia ^b   Ragazzo, Mirko ^b   Bettini, Giordana ^a   Capelli, Paola ^a   D'Alessandro, Emiliano ^b   Nocini, Pier Francesco ^a   Russo, Lucio Lo ^c   Lo Muzio, Lorenzo ^c   Blandamura, Stella ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Bisphosphonate; Jawbone; Metastasis; Osteomyelitis; Osteonecrosis

Indexed keywords

AMOXICILLIN; BISPHOSPHONIC ACID DERIVATIVE; CAPECITABINE; CARBOPLATIN; EPIRUBICIN; GEMCITABINE; METRONIDAZOLE; PACLITAXEL; PAMIDRONIC ACID; STEROID; SULBACTAM; TAMOXIFEN; ZOLEDRONIC ACID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE METASTASIS; BONE NECROSIS; BONE PAIN; BONE RESECTION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; JAW CANCER; LONG TERM CARE; MALE; MANDIBLE; MAXILLA RESECTION; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PAIN; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME;

AGED; BONE NEOPLASMS; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; OSTEONECROSIS; PHOSPHONIC ACIDS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 36148958273     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.08.025     Document Type: Article

References (20)

1. Green J.R. Antitumor effects of bisphosphonates. Cancer 97 (2003) 840-847
2. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
3. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
4. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83-93
5. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
6. Hellstein J.W., and Marek C.L. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?. J Oral Maxillofac Surg 63 (2005) 682-689
7. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
8. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
9. Ruggiero S., Gralow J., Marx R., Hoff A., Schubert M., Huryn J., et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2 (2006) 7-14
10. Bilezikian J.P. Osteonecrosis of the jaw - do bisphosphonates pose a risk?. N Engl J Med 355 (2006) 2278-2281
11. Hirshberg A., Leibovich P., and Buchner A. Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med 23 (1994) 337-341
12. D'Silva N.J., Summerlin D.J., Cordell K.G., Abdelsayed R.A., Tomich C.E., Hanks C.T., et al. Metastatic tumors in the jaws: a retrospective study of 114 cases. J Am Dent Assoc 137 (2006) 1667-1672
13. Hariya Y., Yuasa K., Nakayama E., Kawazu T., Okamura K., and Kanda S. Value of computed tomography findings in differentiating between intraosseous malignant tumors and osteomyelitis of the mandible affecting the masticator space. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 503-509
14. Mignogna M.D., Fedele S., Lo Russo L., Ciccarelli R., and Lo Muzio L. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. J Clin Oncol 24 (2006) 1475-1477
15. Chiandussi S., Biasotto M., Dore F., Cavalli F., Cova M.A., and Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35 (2006) 236-243
16. Pruckmayer M., Glaser C., Nasel C., Lang S., Rasse M., and Leitha T. Bone metastasis with superimposed osteomyelitis in prostate cancer. J Nucl Med 37 (1996) 999-1001
17. Catalano L., Del Vecchio S., Petruzziello F., Fonti R., Salvatore B., Martorelli C., et al. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol 86 (2007) 415-423
18. Weitzman R., Sauter N., Eriksen E.F., Tarassoff P.G., Lacerna L.V., Dias R., et al. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients - May 2006. Crit Rev Oncol Hematol 62 2 (2007 May) 148-152 Epub 2007 Mar 1
19. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4 (2006) 221-233
20. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621